<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01362088</url>
  </required_header>
  <id_info>
    <org_study_id>TPO 767</org_study_id>
    <nct_id>NCT01362088</nct_id>
  </id_info>
  <brief_title>Microcirculation in Continuous Venovenous Hemofiltration Patients on the Intensive Care Unit</brief_title>
  <official_title>Evaluation of Sublingual Microcirculation by Means of SDF Imaging by Stepwise Ultrafiltration in CVVH Patients on the ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical Centre Leeuwarden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical Centre Leeuwarden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In patients where fluid is withdrawn from the bloodstream by Continuous Venovenous
      Hemofiltration (CVVH), the ultrafiltration rate will be calculated for a zero balance. From
      there, the ultrafiltration steps are performed, after increasing the ultrafiltration rate,
      the sublingual microcirculation is assessed by sidestream dark field (SDF). The images are
      subsequently randomly analyzed, and the sublingual microcirculation is expressed as a number,
      the microvascular flow index (MFI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Before deciding to threat a patient actively with CVVH, a target balance will be agreed for
      the next 12 hours. Then the ultrafiltration rate for the zero balance is calculated. From
      there, the ultrafiltration rate progressively increased to 50 ml per hour, up to a maximum
      ultrafiltration rate of 300 ml per hour.

      After each increase of the ultrafiltration rate, the sublingual microcirculation is assessed
      by SDF.

      After obtaining the desired ultrafiltration rate, the microcirculation will again be assessed
      before and after the patient is temporarily placed in Trendelenburg position. This could
      possibly show that underfill has the greatest influence on the microcirculation, and not
      other factors like a rising hematocrit.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in MFI between zero balance and maximal ultrafiltrationrate (300 ml/hr)</measure>
    <time_frame>4 hours</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">14</enrollment>
  <condition>Continuous Venovenous Hemofiltration</condition>
  <arm_group>
    <arm_group_label>CVVH patients</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Intensive Care patients treated with CVVH
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 jaar

          -  informed consent

        Exclusion Criteria:

          -  age &lt; 18 jaar

          -  oral surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christiaan Boerma, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Centre Leeuwarden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical Centre Leeuwarden</name>
      <address>
        <city>Leeuwarden</city>
        <zip>8934 AD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Bemelmans RH, Boerma EC, Barendregt J, Ince C, Rommes JH, Spronk PE. Changes in the volume status of haemodialysis patients are reflected in sublingual microvascular perfusion. Nephrol Dial Transplant. 2009 Nov;24(11):3487-92. doi: 10.1093/ndt/gfp267. Epub 2009 Jun 10.</citation>
    <PMID>19515801</PMID>
  </reference>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 11, 2011</study_first_submitted>
  <study_first_submitted_qc>May 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2011</study_first_posted>
  <last_update_submitted>October 31, 2012</last_update_submitted>
  <last_update_submitted_qc>October 31, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical Centre Leeuwarden</investigator_affiliation>
    <investigator_full_name>E.C. Boerma</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>microcirculation</keyword>
  <keyword>intensive care</keyword>
  <keyword>ultrafiltration</keyword>
  <keyword>CVVH</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

